Skip to main content
Top
Published in: BMC Urology 1/2018

Open Access 01-12-2018 | Research article

Level of invasion into fibromuscular band is an independent factor for positive surgical margin and biochemical recurrence in men with organ confined prostate cancer

Authors: Aram Kim, Myong Kim, Se Un Jeong, Cheryn Song, Yong Mee Cho, Jae Yoon Ro, Hanjong Ahn

Published in: BMC Urology | Issue 1/2018

Login to get access

Abstract

Background

This study aimed investigate the effect of the level of invasion into fibromuscular band (FMB) of prostate on the positive surgical margin (PSM) and biochemical recurrence (BCR) after radical prostatectomy (RP) in patients with organ-confined (pT2) prostate cancer.

Methods

The clinical and pathological data of 461 consecutive patients with pT2 prostate cancer were evaluated regarding the level of invasion into FMB. The relationship between levels of invasion into FMB and PSM / BCR was assessed.

Results

The rate of PSM at an FMB level of at 2 was 18.8%, which was significantly greater than the rates at levels 0 (5.4%) and 1 (7.8%). The level of FMB (p = 0.007) and percentage of tumor volume (p = 0.012) were identified as independent factors predictive of a positive surgical margin in a multivariate analysis. The 5-year BCR-free survival rates for a level 0–1 FMB with negative surgical margin, level 0–1 FMB with positive surgical margin, level 2 FMB with negative surgical margin, and level 2 FMB with positive surgical margin were 96.6%, 86.4%, 85.6%, and 72.9%, respectively (p <  0.001). A level 2 FMB (p = 0.050), positive surgical margin (p = 0.001), and surgical Gleason score (p = 0.001) were identified as independent predictors of a BCR of pT2 prostate cancer.

Conclusions

Among patients with negative surgical margins, the surgical Gleason score and level of FMB independently affected the incidence of a BCR of pT2 prostate cancer. The level of FMB was an independent predictor of both a positive surgical margin and a BCR of pT2 disease. Accordingly, the level of FMB might help to further stratify the prognosis of patients with pT2 disease.
Literature
1.
go back to reference Yossepowitch O, et al. Positive surgical margins after radical prostatectomy: a systematic review and contemporary update. Eur Urol. 2014;65(2):303–13.CrossRefPubMed Yossepowitch O, et al. Positive surgical margins after radical prostatectomy: a systematic review and contemporary update. Eur Urol. 2014;65(2):303–13.CrossRefPubMed
2.
go back to reference Chalfin HJ, et al. Impact of surgical margin status on prostate-cancer-specific mortality. BJU Int. 2012;110(11):1684–9.CrossRefPubMed Chalfin HJ, et al. Impact of surgical margin status on prostate-cancer-specific mortality. BJU Int. 2012;110(11):1684–9.CrossRefPubMed
3.
go back to reference Yossepowitch O, et al. Positive surgical margins in radical prostatectomy: outlining the problem and its long-term consequences. Eur Urol. 2009;55(1):87–99.CrossRefPubMed Yossepowitch O, et al. Positive surgical margins in radical prostatectomy: outlining the problem and its long-term consequences. Eur Urol. 2009;55(1):87–99.CrossRefPubMed
4.
go back to reference Eastham JA, et al. Variations among individual surgeons in the rate of positive surgical margins in radical prostatectomy specimens. J Urol. 2003;170(6 Pt 1):2292–5.CrossRefPubMed Eastham JA, et al. Variations among individual surgeons in the rate of positive surgical margins in radical prostatectomy specimens. J Urol. 2003;170(6 Pt 1):2292–5.CrossRefPubMed
5.
go back to reference Chun FK, et al. Surgical volume is related to the rate of positive surgical margins at radical prostatectomy in European patients. BJU Int. 2006;98(6):1204–9.CrossRefPubMed Chun FK, et al. Surgical volume is related to the rate of positive surgical margins at radical prostatectomy in European patients. BJU Int. 2006;98(6):1204–9.CrossRefPubMed
6.
go back to reference Wheeler TM, et al. Clinical and pathological significance of the level and extent of capsular invasion in clinical stage T1-2 prostate cancer. Hum Pathol. 1998;29(8):856–62.CrossRefPubMed Wheeler TM, et al. Clinical and pathological significance of the level and extent of capsular invasion in clinical stage T1-2 prostate cancer. Hum Pathol. 1998;29(8):856–62.CrossRefPubMed
7.
go back to reference Ayala AG, et al. The prostatic capsule: does it exist? Its importance in the staging and treatment of prostatic carcinoma. Am J Surg Pathol. 1989;13(1):21–7.CrossRefPubMed Ayala AG, et al. The prostatic capsule: does it exist? Its importance in the staging and treatment of prostatic carcinoma. Am J Surg Pathol. 1989;13(1):21–7.CrossRefPubMed
8.
go back to reference Paluru S, Epstein JI. Does the distance between tumor and margin in radical prostatectomy specimens correlate with prognosis: relation to tumor location. Hum Pathol. 2016;56:11–5.CrossRefPubMed Paluru S, Epstein JI. Does the distance between tumor and margin in radical prostatectomy specimens correlate with prognosis: relation to tumor location. Hum Pathol. 2016;56:11–5.CrossRefPubMed
9.
go back to reference Epstein JI, et al. The 2005 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma. Am J Surg Pathol. 2005;29(9):1228–42.CrossRefPubMed Epstein JI, et al. The 2005 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma. Am J Surg Pathol. 2005;29(9):1228–42.CrossRefPubMed
10.
go back to reference Edge, S.B., et al., Prostate, in AJCC cancer staging manual, American joint committee on Cancer, Editor. 2010, Springer: New York. p. 457–468. Edge, S.B., et al., Prostate, in AJCC cancer staging manual, American joint committee on Cancer, Editor. 2010, Springer: New York. p. 457–468.
11.
go back to reference Epstein JI, et al. Prognostic factors and reporting of prostate carcinoma in radical prostatectomy and pelvic lymphadenectomy specimens. Scand J Urol Nephrol Suppl. 2005;216:34–63.CrossRef Epstein JI, et al. Prognostic factors and reporting of prostate carcinoma in radical prostatectomy and pelvic lymphadenectomy specimens. Scand J Urol Nephrol Suppl. 2005;216:34–63.CrossRef
12.
go back to reference Wheeler TM. Anatomic considerations in carcinoma of the prostate. Urol Clin North Am. 1989;16(4):623–34.PubMed Wheeler TM. Anatomic considerations in carcinoma of the prostate. Urol Clin North Am. 1989;16(4):623–34.PubMed
13.
go back to reference Stephenson AJ, et al. Do margins matter? The influence of positive surgical margins on prostate cancer-specific mortality. Eur Urol. 2014;65(4):675–80.CrossRefPubMed Stephenson AJ, et al. Do margins matter? The influence of positive surgical margins on prostate cancer-specific mortality. Eur Urol. 2014;65(4):675–80.CrossRefPubMed
14.
go back to reference Stephenson AJ, et al. Location, extent and number of positive surgical margins do not improve accuracy of predicting prostate cancer recurrence after radical prostatectomy. J Urol. 2009;182(4):1357–63.CrossRefPubMed Stephenson AJ, et al. Location, extent and number of positive surgical margins do not improve accuracy of predicting prostate cancer recurrence after radical prostatectomy. J Urol. 2009;182(4):1357–63.CrossRefPubMed
15.
go back to reference Eastham JA, et al. Prognostic significance of location of positive margins in radical prostatectomy specimens. Urology. 2007;70(5):965–9.CrossRefPubMed Eastham JA, et al. Prognostic significance of location of positive margins in radical prostatectomy specimens. Urology. 2007;70(5):965–9.CrossRefPubMed
16.
go back to reference Roder MA, et al. Risk factors associated with positive surgical margins following radical prostatectomy for clinically localized prostate cancer: can nerve-sparing surgery increase the risk? Scand J Urol. 2014;48(1):15–20.CrossRefPubMed Roder MA, et al. Risk factors associated with positive surgical margins following radical prostatectomy for clinically localized prostate cancer: can nerve-sparing surgery increase the risk? Scand J Urol. 2014;48(1):15–20.CrossRefPubMed
17.
18.
go back to reference Vickers A, et al. The learning curve for surgical margins after open radical prostatectomy: implications for margin status as an oncological end point. J Urol. 2010;183(4):1360–5.CrossRefPubMed Vickers A, et al. The learning curve for surgical margins after open radical prostatectomy: implications for margin status as an oncological end point. J Urol. 2010;183(4):1360–5.CrossRefPubMed
19.
go back to reference Park J, et al. Comparison of oncological outcomes between retropubic radical prostatectomy and robot-assisted radical prostatectomy: an analysis stratified by surgical experience. World J Urol. 2014;32(1):193–9.CrossRefPubMed Park J, et al. Comparison of oncological outcomes between retropubic radical prostatectomy and robot-assisted radical prostatectomy: an analysis stratified by surgical experience. World J Urol. 2014;32(1):193–9.CrossRefPubMed
20.
go back to reference Wieder JA, Soloway MS. Incidence, etiology, location, prevention and treatment of positive surgical margins after radical prostatectomy for prostate cancer. J Urol. 1998;160(2):299–315.CrossRefPubMed Wieder JA, Soloway MS. Incidence, etiology, location, prevention and treatment of positive surgical margins after radical prostatectomy for prostate cancer. J Urol. 1998;160(2):299–315.CrossRefPubMed
21.
go back to reference Song C, et al. Tumor volume, surgical margin, and the risk of biochemical recurrence in men with organ-confined prostate cancer. Urol Oncol. 2013;31(2):168–74.CrossRefPubMed Song C, et al. Tumor volume, surgical margin, and the risk of biochemical recurrence in men with organ-confined prostate cancer. Urol Oncol. 2013;31(2):168–74.CrossRefPubMed
22.
go back to reference Wiegel T, et al. Adjuvant radiotherapy versus wait-and-see after radical prostatectomy: 10-year follow-up of the ARO 96-02/AUO AP 09/95 trial. Eur Urol. 2014;66(2):243–50.CrossRefPubMed Wiegel T, et al. Adjuvant radiotherapy versus wait-and-see after radical prostatectomy: 10-year follow-up of the ARO 96-02/AUO AP 09/95 trial. Eur Urol. 2014;66(2):243–50.CrossRefPubMed
23.
go back to reference Bolla M, et al. Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911). Lancet. 2012;380(9858):2018–27.CrossRefPubMed Bolla M, et al. Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911). Lancet. 2012;380(9858):2018–27.CrossRefPubMed
24.
go back to reference Thompson IM, et al. Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial. J Urol. 2009;181(3):956–62.CrossRefPubMedPubMedCentral Thompson IM, et al. Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial. J Urol. 2009;181(3):956–62.CrossRefPubMedPubMedCentral
25.
go back to reference Wiegel T, et al. Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95. J Clin Oncol. 2009;27(18):2924–30.CrossRefPubMed Wiegel T, et al. Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95. J Clin Oncol. 2009;27(18):2924–30.CrossRefPubMed
26.
go back to reference Steuber T, et al. Comparative assessment of the 1992 and 2002 pathologic T3 substages for the prediction of biochemical recurrence after radical prostatectomy. Cancer. 2006;106(4):775–82.CrossRefPubMed Steuber T, et al. Comparative assessment of the 1992 and 2002 pathologic T3 substages for the prediction of biochemical recurrence after radical prostatectomy. Cancer. 2006;106(4):775–82.CrossRefPubMed
Metadata
Title
Level of invasion into fibromuscular band is an independent factor for positive surgical margin and biochemical recurrence in men with organ confined prostate cancer
Authors
Aram Kim
Myong Kim
Se Un Jeong
Cheryn Song
Yong Mee Cho
Jae Yoon Ro
Hanjong Ahn
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Urology / Issue 1/2018
Electronic ISSN: 1471-2490
DOI
https://doi.org/10.1186/s12894-018-0321-z

Other articles of this Issue 1/2018

BMC Urology 1/2018 Go to the issue